1-1 of 1
Jana Rabasova, M.S.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Successful Treatment with Imatinib Mesylate Significantly Decreases Plasma Levels of Vascular Endothelial Growth Factor (VEGF) and Soluble Endoglin (sCD105) but Not Basic Fibroblast Growth Factor (bFGF) or Angiopoietin-2 (Ang-2) in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase

Lukas Smolej, MD, PhD, Ctirad Andrys, M.S., Ph.D., Jaroslava Voglova, M.D., Petra Belohlavkova, M.D., Jana Rabasova, M.S., Martin Beranek, PharmDr. Ph.D., Jaroslav Maly, M.D., Ph.D.
Journal: Blood
Blood (2008) 112 (11): 4252.
https://doi.org/10.1182/blood.V112.11.4252.4252
Published: 2008